Therapeutic Gene Editing Companies

This is the first comprehensive list of companies that are developing therapies with technologies that edit genes inside cells (namely CRISPR-, ZFN-, TALEN- based technologies). The database started with 46 companies through the end of 2018 and the first update has 60 companies through May 2019. The subscription covers one year of periodic updates. This dataset is compiled by Alexey Bersenev MD PhD from public information sources.

For each company:

  1. Company name
  2. Link to company website
  3. Country of origin
  4. Key partner or licensee
  5. Stage of development (preclinical or clinical)
  6. Gene Editing Technology (CRISPR-, ZFN-, TALEN-, etc.)
  7. Type of edit (ex vivo/in vivo)
  8. Therapeutic area(s)


  • Only companies that provide therapeutic gene editing.
  • Companies developing gene editing therapy either in-house or via relationships, or that have assets (via licensing or partnership) with therapeutic products.


  • Exclude companies selling gene editing tools and services.
  • Exclude manufacturers of gene editing tools/reagents.
Public samples: